Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings of a Workshop

Advancing the Discipline of Regulatory Science for Medical Product Development: An Update on Progress and a Forward-Looking Agenda: Workshop Summary

Virtual Clinical Trials: Challenges and Opportunities: Proceedings of a Workshop

The Role of Digital Health Technologies in Drug Development: Proceedings of a Workshop

Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development: Proceedings of a Workshop

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources: Proceedings of a Workshop

Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary

Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary

Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary

Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary

Challenges for the FDA: The Future of Drug Safety: Workshop Summary

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary

Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting: Proceedings of a Workshop

Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop

Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary

Addressing the Barriers to Pediatric Drug Development: Workshop Summary

Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary

Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research

Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary